Bio-Techne Announces Appointment Of Julie L. Bushman To Its Board Of Directors

Rhea-AI Summary

Bio-Techne Corporation (NASDAQ:TECH) appointed Julie L. Bushman as an independent director effective July 31, 2020. The board now comprises ten directors, with nine being independent. Bushman, former Executive Vice President at 3M, has extensive experience in global operations, digital software, and CIO roles. Her addition aims to enhance Bio-Techne's global expansion and operational efficiencies.

Positive

• Julie L. Bushman's appointment brings valuable global experience from her time at 3M.
• The board's strong independent director representation strengthens governance.

Negative

• None.

Argus Session date unavailable

+1.35% session move Open Argus

Details

News Market Reaction – TECH

The recorded move for TECH in the trading session of this news was +1.35%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MINNEAPOLIS, Aug. 3, 2020 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced the appointment of Julie L. Bushman to serve as an independent director on the company's board of directors, effective as of July 31, 2020.  Following the appointment, the board of Bio-Techne will be comprised of ten directors, nine of whom are independent.

Bushman, 59, is the former Executive Vice President of International Operations for 3M.  She previously served in various executive positions at 3M, including as Senior Vice President of Business Transformation and Information Technology; Executive Vice President of Safety, Security and Protection Services; Executive Vice President of Safety and Graphics; Division Vice President of the Occupational Health and Environmental Safety Division; and Chief Information Officer.  Bushman joined 3M in 1983.

Bushman currently serves as a director of Adient plc, an automotive seating company and Phillips 66, an energy manufacturing and logistics company, and the Regions Hospital Foundation.  She previously served as a director of Johnson Controls from 2012 through 2016.  

"We are pleased to welcome Julie to our board," said Bob Baumgartner, Chair of the Board of Bio-Techne. "She brings tremendous global experience from managing 3M's international operations, as well as other global business roles while at 3M. She also has extensive digital, software and CIO experience, which will bring important expertise as Bio-Techne continues to expand globally and integrate systems to increase operational efficiencies."

About Bio-Techne Corporation (NASDAQ:TECH) 

Contact: David Clair, Senior Director, Investor Relations & Corporate Development 
david.clair@bio-techne.com 
612-656-4416 

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/bio-techne-announces-appointment-of-julie-l-bushman-to-its-board-of-directors-301104251.html

SOURCE Bio-Techne Corporation

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who is Julie L. Bushman and what role will she play at Bio-Techne?

Julie L. Bushman is the newly appointed independent director at Bio-Techne, effective July 31, 2020, bringing extensive global operational experience from her prior role at 3M.

When was the appointment of Julie L. Bushman announced?

The appointment of Julie L. Bushman was announced on August 3, 2020.

What impact might Julie L. Bushman's experience have on Bio-Techne?

Her experience in global operations and technology may enhance Bio-Techne's international growth and operational efficiencies.

How many directors does Bio-Techne's board have after this appointment?

After the appointment, Bio-Techne's board has ten directors, nine of whom are independent.